Hydroxyurea in two pregnant women with sickle cell anemia

Pharmacotherapy

Volumn 19, Issue 12, 1999, Pages 1459-1462

  Byrd, Debbie C ^a,b,d   Pitts, Shea R ^c   Alexander, Chelley K ^b  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

^c UNIVERSITY OF ALABAMA HOSPITAL   (United States)

^d Capstone Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROXIA; HYDROXYUREA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; ECLAMPSIA; FEMALE; HIGH RISK PREGNANCY; HUMAN; SICKLE CELL ANEMIA; STILLBIRTH; TERATOGENICITY; THROMBOCYTHEMIA;

EID: 0032711232     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.18.1459.30901     Document Type: Article

References (21)

1. Bristol-Myers Squibb Oncology Division. Droxia (hydroxyurea) package insert. Princeton, NJ;1998.
2. Anonymous. FDA categories for drug use in pregnancy. Fed Register 1980;44:37434-67.
3. Aliverti V, Bonanomi L, Giavini E. Hydroxyurea as a reference standard in teratological screening: comparison of the embryotoxic and teratogenic effects following single intraperitoneal or repeated oral administration to pregnant rats. Arch Toxicol 1980;4(suppl 4):239-47.
4. Seller MJ, Perkins KJ. Effect of hydroxyurea on neural tube defects in the curly-tail mouse. J Craniofac Genet Dev Biol 1983;3:11-17.
5. DePass LR, Weaver EV. Comparison of teratogenic effects of aspirin and hydroxyurea in the Fischer 344 and Wistar strains. J Toxicol Environ Health 1982;10:297-305.
6. Desesso JM, Scialli AR, Goeringer GC. D-Mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity of hydroxyurea in rabbits. Teratology 1994;49:248-59.
7. Patel M, Dukes IAF, Hull JC. Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report. Am J Obstet Gynecol 1991;165:565-6.
8. Tertian G, Tchernia G, Papiernik E, Elefant E. Hydroxyurea and pregnancy [letter]. Am J Obstet Gynecol 1992;166:1868.
9. Delmer A, Rio B, Bauduer F, Ajchenbaum F, Marie JP, Zittoun R. Pregnancy during myelosuppressive treatment for chronic myelogenous leukaemia [letter]. Br J Haematol 1992;82:783-4.
10. Jackson N, Shukri A, Ali K. Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy. Br J Haematol 1993;85:203-4.
11. Szanto F, Kovacs L. Successful delivery following continuous cytostatic therapy of a leukemic pregnant woman [in Hungarian]. Orv Hetil 1993;134:527-9.
12. Cinkotai KI, Wood P, Donnai P, Kendra J. Pregnancy after treatment with hydroxyurea in a patient with primary thrombocythaemia and a history of recurrent abortion. J Clin Pathol 1994;47:769-70.
13. Fitzgerald, JM, McCann MB. The combination of hydroxyurea and leucapheresis in the treatment of chronic myeloid leukaemia in pregnancy. Clin Lab Haematol 1993;15:63-5.
14. Doney KC, Shepard TH. Combination chemotherapy for acute myelocytic leukemia during pregnancy: three case reports. Cancer Treat Rep 1979;63:369-71.
15. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
16. Diav-Citrin O, Hunnisett L, Sher GD, Keren G. Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature. Am J Hematol 1999;60:148-50.
17. Schechter AN, Rodgers GP. Sickle cell anemia: basic research reaches the clinic. N Engl J Med 1995;332:1372-4.
18. Powars DR. Natural history of sickle cell disease: the first two decades. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:395-412.
19. Koshy M, Burd L. Obstetric and gynecologic issues. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:689-702.
20. Rodgers GP. Overview of pathophysiology and rationale for treatment of sickle cell anemia. Semin Hematol 1997;34(suppl 3):2-7.
21. Howard LW, Kennedy LD. Hydroxyurea in the treatment of sickle cell anemia. Ann Pharmacother 1997;31:1393-6.